CannabisNewsBreaks Archive - Page 2 of 233

TuesdaySep 17, 2019 2:23 pm

CannabisNewsBreaks – GB Sciences, Inc. (GBLX) Sells 50% Ownership Stake in GB Sciences Louisiana, LLC

GB Sciences (OTCQB: GBLX) today announced that it has filed an 8k announcing the sale of its 50% ownership stake in GB Sciences Louisiana, LLC. for $16 million. The stake will be bought by Wellcana Plus at a fee of $7 million in cash at closing, $1 million in cash within 60 days of closing, and the remaining $8 million as an earn out. The profitability of the Louisiana operations will determine the proceeds realized through the earn out as well as the timing of those proceeds. The sale enables GBLX to focus on attaining a DEA license, profitability and…

TuesdaySep 17, 2019 11:37 am

CannabisNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) Appoints Consumer Products and Healthcare Industry Veteran Peter Vitulli to its Board

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) this morning announced its appointment of Peter Vitulli to its board of directors. According to the update, Vitulli currently serves as an operating advisor at Windrose Health Investors and has extensive experience spanning 35 years in the consumer products and healthcare industries with both large corporations and entrepreneurial start-ups. Earlier in his career, Peter was president and general manager of the $1 billion North American Gatorade business. He most recently served as president and CEO of DNA Diagnostics Center, one of the world's largest providers of private DNA tests. "I have a long-standing…

TuesdaySep 17, 2019 10:57 am

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Announces Plans to Participate at the Eight Capital & Cassels Brock Global Cannabis Conference

Willow Biosciences Inc. (CSE: WLLW) today announced its plans to participate at the Eight Capital & Cassels Brock Global Cannabis Conference slated to be held at the Shangri-La Hotel in Toronto on September 19, 2019. Willow Biosciences will be available for one-on-one meetings during the event. In addition, Willow CEO, President and Director Trevor Peters will present in the panel, “Pushing the Boundaries Through Technology, Innovation & Research,” at 10:30 a.m. Eastern Time in the Queen's Park Ballroom. To view the full press release, visit http://cnw.fm/LS4j3 About Willow Biosciences Inc. Willow is a Canadian biotechnology company based in Calgary, Alberta,…

TuesdaySep 17, 2019 10:17 am

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Announces Partnership with Linneo Health to Supply Medical Cannabis in Europe

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced that it has engaged with Linneo Health S.L., a subsidiary of Alcaliber S.A., to be its European medical cannabis supply partner. A European leader in the pharmaceutical cannabis industry, Linneo Health recently received its EU-GMP (“Good Manufacturing Practices”) certification from the Spanish regulatory authorities. According to the update, the multi-year agreement includes increasing supply volumes as VIVO expands in the European medical market. "Our partnership with Linneo Health is part of our strategic priority to accelerate international market growth," VIVO CEO Barry Fishman said in the news release. "We are…

TuesdaySep 17, 2019 10:03 am

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Enters Distribution Agreement to Launch Medical Cannabis Inhaler in Canada

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has entered into a distribution agreement with Israel-based pharma-tech company Syqe Medical, Ltd. to launch Syqe's flagship product, the Syqe(TM) Inhaler, in Canada. The Syqe Inhaler is a metered-dose medical cannabis inhaler that provides quick pain relief while decreasing psychoactive effects and enabling patients to go about their normal daily activities. The inhaler’s use of metered dosing allows patients and healthcare providers to consistently deliver treatment at pharmaceutical standards. Through its wholly owned subsidiaries, TerrAscend…

TuesdaySep 17, 2019 9:48 am

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Human CBD Study Results Published in Peer Reviewed Clinical Journal

Global innovator in drug delivery platforms Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announced the publication of final study results of the 2018 human clinical study evaluating CBD delivery and effectiveness using its patented DehydraTECH(TM) powered TurboCBD(TM); capsules. According to the update results were published in the peer reviewed medical journal, Advances in Therapy, which focuses on clinical medicine and pharmaceutical research and has been published continually since 1984. Lexaria reported several key findings highlighted in the publication, including but not limited to: CBD in-plasma levels with the 90mg dose of TurboCBD were significantly higher than with the generic…

MondaySep 16, 2019 11:33 am

CannabisNewsBreaks – Fifth Annual New West Summit’s Carefully Curated Roster Includes Leafwire Pitch Slam

One of the premiere events for cannabis tech, the New West Summit, is slated to return to San Francisco for its fifth annual conference at the Bespoke event center from October 10-11, 2019. Known as THE cannabis tech conference, the New West Summit has a full roster with over 50 exhibitors, more than 100 speakers and several exciting events. The summit will include the Leafwire Pitch Slam, sponsored by Leafwire, a cannabis business network, that will allow ten cannabis start-ups to compete as they pitch their business to industry professionals for a grand prize of $10,000. To view the full…

MondaySep 16, 2019 11:10 am

CannabisNewsBreaks – ChineseInvestors.com Inc. (CIIX) to Present at the MicroCap Conference in New York City on September 17

Established financial news and investment portal for the global Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX) today announced that CFO Alex P. Hamilton of its subsidiary, CBD Biotech, Inc., is scheduled to present at the MicroCap Conference. The exclusive event, dedicated to connecting small and micro-cap companies with high-level, institutional and retail investors, is slated to be held at the JW Marriot Essex House in New York City on September 16 -17, 2019. CIIX’s presentation is scheduled for Tuesday, September 17, 2019, at 1:00 p.m. Eastern Time in Room 1. To view the full press release, visit http://cnw.fm/Nh76h About ChineseInvestors.com Founded in…

MondaySep 16, 2019 9:49 am

CannabisNewsBreaks – Grapefruit Boulevard Investments Inc. (IGNG) Enters MOU with “Patchless Patch” Patent Holder for Timed Release Delivery of Grapefruit’s Cannabis Products

Grapefruit Boulevard Investments (OTCQB: IGNG), a Los Angeles based cannabis company which has been licensed by the state of California to both manufacture and distribute cannabis products in California since January 2018, today announced its August 22, 2019, entry into a formal Memorandum of Understanding (“MOU”) with a privately held manufacturer of a novel patented and trademarked delivery system (the “patchless patch”). The delivery system is comprised of highly engineered microscopic particles that topically deliver a therapeutic payload to the user over an extended period of time. According to the update, the MOU is binding on both parties, and both…

FridaySep 13, 2019 2:36 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Developing Novel Nicotine Ingestion Method as Smoking Alternative

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), an innovative biotechnology company, has set its sights on using its proprietary drug delivery technology to provide an alternative method of nicotine ingestion that is safer than smoking. An article further discussing the company reads, “The technology, known as DehydraTECH(TM), is a patented, cost-effective delivery mechanism that has been shown to improve the ingestibility of cannabinoids, vitamins, nonsteroid anti-inflammatory drugs (NSAIDs) and nicotine. Now, Lexaria has partnered with one of the world’s largest tobacco firms to develop new, reduced-risk, oral nicotine products using the technology (http://cnw.fm/8nSR1). . . . The deal funds Lexaria’s R&D program…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

CannabisNewsBreaks